Silvestro Stephen L 4
4 · OptimizeRx Corp · Filed Oct 7, 2025
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Silvestro Stephen L
Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-10-03−6,649→ 0 total→ Common Stock (6,649 underlying) - Sale
Common Stock
2025-10-03$18.75/sh−1,620$30,375→ 188,916 total - Exercise/Conversion
Common Stock
2025-10-03+6,649→ 190,536 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.